Chefs' Warehouse Inc
Change company Symbol lookup
Select an option...
CHEF Chefs' Warehouse Inc
FRBA FIRST BANK (Hamilton)
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MMM 3M Co
MPX Marine Products Corp
Go

Consumer Staples : Food & Staples Retailing | Small Cap Blend
Company profile

The Chefs' Warehouse, Inc. is a distributor of specialty food products in the United States and Canada. The Company operates through food product distribution segment, which is concentrated on the East and West Coasts of the United States. The Company is focused on serving the specific needs of chefs owning and/or operating some of the menu-driven independent restaurants, fine dining establishments, Country clubs, hotels, caterers, culinary schools, bakeries, patisseries, chocolatiers, cruise lines, casinos and specialty food stores in the United States and Canada. Its product portfolio consists of imported and domestic specialty food products, such as artisan charcuterie, specialty cheeses, oils and vinegars, truffles, caviar, chocolate and pastry products. The Company also offers a line of center-of-the-plate products, including custom cut beef, seafood and hormone-free poultry, as well as food products, such as cooking oils, butter, eggs, milk and flour.

Price
Delayed
$12.84
Day's Change
-2.73 (-17.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
14.13
Day's Low
12.82
Volume
(Heavy Day)

Today's volume of 856,787 shares is on pace to be much greater than CHEF's 10-day average volume of 541,404 shares.

856,787

Pfizer Hosts Virtual Investor Day

8:00 am ET September 14, 2020 (BusinessWire) Print

Pfizer Inc. (NYSE: PFE) will host its virtual Investor Day today and tomorrow: Monday, September 14, 2020 from 1:00 p.m. EDT to 3:45 p.m. EDT and Tuesday, September 15, 2020 from 10:00 a.m. EDT to 1:30 p.m. EDT. Pfizer business executives and scientific leadership will provide updates on the company's progress in advancing its R&D pipeline, specifically on product candidates with blockbuster potential that are expected to launch by 2025.

The agenda for Pfizer's Investor Day is as follows:

DAY 1                                                                     DAY 2
Monday September 14, 2020 | 1:00 p.m. - 3:45 p.m. ET                      Tuesday September 15, 2020 | 10:00 a.m. - 1:30 p.m. ET
------------------------------------------------------------------------- ---------------------------------------------------------------------------
1:00 p.m.                                                                 10:00 a.m.
Welcome & Introduction to Day 1                                           Welcome & Introduction to Day 2
Speaker: Chuck Triano                                                     Speaker: Chuck Triano
------------------------------------------------------------------------- ---------------------------------------------------------------------------
1:05 p.m.                                                                 10:05 a.m.
Executive Leadership Team Plenary Session                                 Inflammation & Immunology Triad Presentation and Q&A
Pfizer "Big Picture" Speakers: Richard Blackburn, Michael Corbo, Michael Vincent & Tamas Koncz
Speaker: Albert Bourla
R&D Turnaround Story
Speaker: Mikael Dolsten
Productivity of Clinical Change
Speaker: Rod MacKenzie
Pfizer Biopharmaceuticals Group Core Therapeutic Area Overview
Speaker: Angela Hwang
                                                                          ---------------------------------------------------------------------------
-------------------------------------------------------------------------
10 Minute Break                                                           10 Minute Break
------------------------------------------------------------------------- ---------------------------------------------------------------------------
2:15 p.m.                                                                 11:45 a.m.
Internal Medicine Triad Presentation and Q&A                              Oncology Triad Presentation and Q&A
Speakers: Michael Gladstone, James Rusnak & Morris Birnbaum               Speakers: Andy Schmeltz, Chris Boshoff, Jeff Settleman & Nicholas Saccomano
------------------------------------------------------------------------- ---------------------------------------------------------------------------
3:00 p.m.                                                                 5 Minute Break
Vaccines Tetrad Presentation and Q&A
Speakers: Nanette Cocero, Luis Jodar, Kathrin Jansen & William Gruber
                                                                          ---------------------------------------------------------------------------

To access the live webcast, including audio, video and presentation slides, visit our web site at www.pfizer.com/investors. The webcast can also be accessed directly at www.PfizerInvestorDay.virtualeventsite.com. Participants are advised to register in advance.

Investors and analysts will also have an opportunity to ask questions in live Q&A sessions with speakers. Those participants who would like to ask a question can dial either (833) 711-4985 in the United States and Canada or (916) 637-9673 outside of the United States and Canada. The password is "Pfizer2020". Members of the media are invited to monitor the call by dialing (833) 711-4985 in the United States and Canada or (916) 637-9673 outside of the United States and Canada with the password "Pfizer2020". Journalists who wish to ask questions are requested to contact a member of Pfizer's Media Relations team.

Interested parties unable to watch the live webcast will be able to view and listen to an archived copy of the webcast, which will be available on www.pfizer.com/investors following the conclusion of the event.

About Pfizer: Breakthroughs That Change Patients' Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects, expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, revenue contribution, growth, performance, timing of exclusivity and potential benefits, manufacturing and product supply, our efforts to respond to COVID-19, including our investigational vaccine candidate against SARS-CoV-2 and our investigational protease inhibitor, our expectations regarding the impact of COVID-19, our ability to successfully capitalize on growth opportunities and prospects, plans for and prospects of our acquisitions and other business development activities, including our proposed transaction with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new global pharmaceutical company and plans relating to share repurchases and dividends, among other things, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results", as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200914005083/en/

SOURCE: Pfizer Inc.

Media Relations: 
Amy Rose 
+1 (646) 592-3157 
Amy.Rose@Pfizer.com 


Investor Relations: 
Ryan Crowe 
+1 (212) 733-8160 
Ryan.Crowe@Pfizer.com
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.